Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline M Moore

Showing results (181-190 of 231) with videos related to

Pageof 24
Sort By:
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 4, 2025
Geographic variability in contemporary utilization of PET imaging for prostate cancer: a medicare claims cohort studyStephan M Korn, Zhiyu Qian, Hanna Zurl, et al.
British Journal of Cancer|March 29, 2017
The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsyLucy A M Simmons, Abi Kanthabalan, Manit Arya, et al.
AJR. American Journal of Roentgenology|August 20, 2020
PI-RADS Committee Position on MRI Without Contrast Medium in Biopsy-Naive Men With Suspected Prostate Cancer: Narrative ReviewIvo G Schoots, Jelle O Barentsz, Leonardo K Bittencourt, et al.
European Urology Focus|April 26, 2021
Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance ImagingTeresa Marsden, Neil McCartan, Joanna Hadley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Geographic Variability in Germline Genetic Testing for Prostate Cancer: A Nationwide Medicare Claims Study With Evidence of Low UptakeStephan M Korn, Zhiyu Qian, Hanna Zurl, et al.
BMJ Open|October 1, 2021
ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRITeresa Marsden, Derek J Lomas, Neil McCartan, et al.
European Urology Oncology|February 14, 2021
Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical ProstatectomyValeria Panebianco, Geert Villeirs, Jeffrey C Weinreb, et al.
Plos One|August 27, 2019
Prediction of significant prostate cancer in biopsy-naïve men: Validation of a novel risk model combining MRI and clinical parameters and comparison to an ERSPC risk calculator and PI-RADSJan Philipp Radtke, Francesco Giganti, Manuel Wiesenfarth, et al.
BMJ Open|April 5, 2023
Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocolAqua Asif, Arjun Nathan, Alexander Ng, et al.
Insights Into Imaging|July 6, 2022
Promoting the use of the PRECISE score for prostate MRI during active surveillance: results from the ESOR Nicholas Gourtsoyiannis teaching fellowshipFrancesco Giganti, Laurene Aupin, Camille Thoumin, et al.
Pageof 24

Showing results (181-190 of 231) with videos related to

Sort By:
Pageof 24
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 4, 2025
Geographic variability in contemporary utilization of PET imaging for prostate cancer: a medicare claims cohort studyStephan M Korn, Zhiyu Qian, Hanna Zurl, et al.
British Journal of Cancer|March 29, 2017
The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsyLucy A M Simmons, Abi Kanthabalan, Manit Arya, et al.
AJR. American Journal of Roentgenology|August 20, 2020
PI-RADS Committee Position on MRI Without Contrast Medium in Biopsy-Naive Men With Suspected Prostate Cancer: Narrative ReviewIvo G Schoots, Jelle O Barentsz, Leonardo K Bittencourt, et al.
European Urology Focus|April 26, 2021
Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance ImagingTeresa Marsden, Neil McCartan, Joanna Hadley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Geographic Variability in Germline Genetic Testing for Prostate Cancer: A Nationwide Medicare Claims Study With Evidence of Low UptakeStephan M Korn, Zhiyu Qian, Hanna Zurl, et al.
BMJ Open|October 1, 2021
ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRITeresa Marsden, Derek J Lomas, Neil McCartan, et al.
European Urology Oncology|February 14, 2021
Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical ProstatectomyValeria Panebianco, Geert Villeirs, Jeffrey C Weinreb, et al.
Plos One|August 27, 2019
Prediction of significant prostate cancer in biopsy-naïve men: Validation of a novel risk model combining MRI and clinical parameters and comparison to an ERSPC risk calculator and PI-RADSJan Philipp Radtke, Francesco Giganti, Manuel Wiesenfarth, et al.
BMJ Open|April 5, 2023
Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocolAqua Asif, Arjun Nathan, Alexander Ng, et al.
Insights Into Imaging|July 6, 2022
Promoting the use of the PRECISE score for prostate MRI during active surveillance: results from the ESOR Nicholas Gourtsoyiannis teaching fellowshipFrancesco Giganti, Laurene Aupin, Camille Thoumin, et al.
Pageof 24